Congenital toxoplasmosis: therapeutic strategies.

Foulon, W

Foulon, W.

Affiliation

Foulon W; Department of Obstetrics, Academisch Ziekenhuis, Vrije Universiteit Brussel, Brussels, Belgium. walter.foulon@az.vub.ac.be

Arch Pediatr ; 10 Suppl 1: 10-1, 2003 Feb.

Article in En | MEDLINE | ID: mdl-12802954

Subject(s)

Pregnancy Complications, Parasitic/drug therapy; Toxoplasmosis, Congenital/drug therapy; Animals; Antiprotozoal Agents/therapeutic use; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical/prevention & control; Neonatal Screening; Pregnancy; Pregnancy Complications, Parasitic/diagnosis; Pregnancy Outcome; Prenatal Care/methods; Primary Prevention/methods; Pyrimethamine/therapeutic use; Research Design/standards; Spiramycin/therapeutic use; Sulfonamides/therapeutic use; Toxoplasmosis, Congenital/diagnosis; Toxoplasmosis, Congenital/transmission; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Toxoplasmosis, Congenital / Pregnancy Complications, Parasitic Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Female / Humans / Newborn / Pregnancy Language: En Journal: Arch Pediatr Year: 2003 Document type: Article Affiliation country: Belgium

Search on Google

Add to My VHL

XML

PubMed Links